APA (7th ed.) Citation

JH, C., PB, W., MS, S., RD, G., AW, L., NA, K., . . . WA, L. (2021). SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma. Science translational medicine, 13(591), . https://doi.org/10.1126/scitranslmed.abe7378

Chicago Style (17th ed.) Citation

JH, Choe, et al. "SynNotch-CAR T Cells Overcome Challenges of Specificity, Heterogeneity, and Persistence in Treating Glioblastoma." Science Translational Medicine 13, no. 591 (2021). https://doi.org/10.1126/scitranslmed.abe7378.

MLA (9th ed.) Citation

JH, Choe, et al. "SynNotch-CAR T Cells Overcome Challenges of Specificity, Heterogeneity, and Persistence in Treating Glioblastoma." Science Translational Medicine, vol. 13, no. 591, 2021, https://doi.org/10.1126/scitranslmed.abe7378.